Sponsor:
Bayer
Code:
NCT05850520
Conditions
Macular Edema Secondary to Retinal Vein Occlusion
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg
Sham
Fluorescein
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations